Skip to main content
Clinical Trials/JPRN-UMIN000004624
JPRN-UMIN000004624
Recruiting
N/A

Prospective study about the improvement of therapeutic invasiveness by oral intake of branched-chain amino acid (BCAA) supplement in hepatocellular carcinoma (HCC) patients after transcatheter arterial chemoembolization (TACE) and radiofrequency ablation (RFA) - Prospective study about the improvement of therapeutic invasiveness by oral intake of BCAA supplement in HCC patients after TACE and RFA

Department of Gastroenterology, Kobe University Graduate School of Medicine0 sites150 target enrollmentNovember 29, 2010

Overview

Phase
N/A
Intervention
Not specified
Conditions
Hepatocellular carcinoma
Sponsor
Department of Gastroenterology, Kobe University Graduate School of Medicine
Enrollment
150
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
November 29, 2010
End Date
March 1, 2016
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Department of Gastroenterology, Kobe University Graduate School of Medicine

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Those who had refractory ascites, overt hepatic encephalopathy, uncontrolled esophageal varices, severe jaundice, Child's grade C and portal vein trunk thrombosis were excluded from the study. In addition, those who used intravenous albumin regularly were also excluded.

Outcomes

Primary Outcomes

Not specified

Similar Trials